Trial · NCT03703908
Results by group20
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 20
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| The Number of Subjects With a Reduction in Urine Protein to Creatinine Ratio (UPCR) of at Least 20% | CCX140-B | 2 | Participants | ||
| Achievement of Partial or Complete Remission of UPCR Through Week 12 and Through the End of Treatment | CCX140-B | No Complete or Partial remission at week 12/ end of treatment | 4 | Participants | |
| Achievement of Partial or Complete Remission of UPCR Through Week 12 and Through the End of Treatment | CCX140-B | Partial remission at Week 12 | 1 | Participants | |
| Proportion of Subjects With Achievement of Complete Remission During the Treatment Period | CCX140-B | Achieved complete remission | 0 | Participants | |
| Proportion of Subjects With Achievement of Complete Remission During the Treatment Period | CCX140-B | Did not achieve complete remission | 5 | Participants | |
| Time Taken of Subjects to Achieve Complete Remission During the Treatment Period | CCX140-B | NA | days | ||
| Change From Baseline in Urine Protein:Creatinine Ratio (UPCR) Over Time | CCX140-B | Week 12 | -1.3100 | Standard Deviation 3.76247 | g protein/g creatinine |
| Change From Baseline in Urine Protein:Creatinine Ratio (UPCR) Over Time | CCX140-B | Week 52 | -0.4985 | Standard Deviation 3.37926 | g protein/g creatinine |
| Assessment of Time to and Proportion of Subjects With Achievement of Partial Remission During the Treatment Period | CCX140-B | Partial remission at Week 12 | 1 | Participants | |
| Assessment of Time to and Proportion of Subjects With Achievement of Partial Remission During the Treatment Period | CCX140-B | Did not achieve partial remission | 4 | Participants | |
| Mean Change From Baseline for eGFR Using the CKD-EPI Cystatin C Equation Over Time | CCX140-B | Week 12 | 7.50 | Full Range -11.0 to 37.0 | mL/min/1.73m² |
| Mean Change From Baseline for eGFR Using the CKD-EPI Cystatin C Equation Over Time | CCX140-B | Week 52 | -2.00 | Full Range -2.0 to -2.0 | mL/min/1.73m² |
| Mean Change From Baseline for the eGFR CKD-EPI Creatinine Equation Over Time | CCX140-B | Week 12 | -14.50 | Full Range -27.0 to -6.0 | ml/min/1.73 m² |
| Mean Change From Baseline for the eGFR CKD-EPI Creatinine Equation Over Time | CCX140-B | Week 52 | -15.0 | Full Range -15.0 to -15.0 | ml/min/1.73 m² |
| Mean Change From Baseline for eGFR CKD-EPI Creatinine-Cystatin C Equation Over Time | CCX140-B | Week 12 | -2.25 | Full Range -18.0 to 13.0 | ml/min/1.73 m² |
| Mean Change From Baseline for eGFR CKD-EPI Creatinine-Cystatin C Equation Over Time | CCX140-B | Week 52 | -8.0 | Full Range -8.0 to -8.0 | ml/min/1.73 m² |
| Mean Change From Baseline for the MDRD Creatinine Equation Over Time | CCX140-B | Week 12 | -12.75 | Full Range -24.0 to -5.0 | ml/min/1.73 m² |
| Mean Change From Baseline for the MDRD Creatinine Equation Over Time | CCX140-B | Week 52 | -13.00 | Full Range -13.00 to -13.00 | ml/min/1.73 m² |
| Effect of CCX140-B Treatment on Quality of Life Endpoint EQ-5D-5L for the Overall Trial | CCX140-B | Week 12 | 66.3 | Standard Deviation 31.98 | score on a scale |
| Effect of CCX140-B Treatment on Quality of Life Endpoint EQ-5D-5L for the Overall Trial | CCX140-B | Week 52 | 85 | Standard Deviation 0 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03703908/results